相关实验视频

Updated: Jun 7, 2025

Measuring Lactase Enzymatic Activity in the Teaching Lab

Measuring Lactase Enzymatic Activity in the Teaching Lab

Published on: August 6, 2018

高风险怀孕中的乳腺生成II延迟:我们应该注意什么

Qianqian Liu¹, Hanxiang Lin¹

¹Department of Obstetrics, The First Affiliated Hospital of Soochow University, Suzhou, China.

Biological research for nursing

|November 13, 2024

概括

延迟乳腺生成II (DOL II) 影响41%的高风险母亲. 晚期母亲年龄,妊娠期糖尿病和高血压是延迟乳生产的关键风险因素,需要改善产后支持.

科学领域:

产科产科产科产科产科
新生儿护理新生儿护理
哺乳期科学哺乳期科学

背景情况:

及时启动乳糖生成II对于产后恢复和婴儿营养至关重要.
乳生成II的延迟可能会导致母亲和孩子的重大临床并发症.
识别延迟乳腺生成II (DOL II) 的决定因素对于高风险怀孕的有针对性的干预措施至关重要.

研究的目的:

评估在高危孕妇中导致乳腺发育 II (DOL II) 延迟的因素.
为管理 DOL II. 的临床干预和产后护理策略提供信息.
在一个脆弱的产妇群体中,确定与延迟乳生产相关的特定风险因素.

主要方法:

研究了一组206名高风险孕妇,这些孕妇被送往产科重症监护室.
用皮尔森相关性分析和后勤回归来确定DOL II的预测因素.
数据收集发生在2023年2月1日至2024年4月30日之间,重点关注产后监测.

主要成果:

在206名参与者中,有85人 (41.26%) 经历了乳腺发育 II (DOL II) 的延迟.
在DOL II和孕妇年龄 (r=0.452),妊娠高血压 (r=0.514),妊娠糖尿病 (r=0.487) 和延迟胆乳液分泌 (r=0.506) 之间发现了显著的相关性.
对于DOL II的独立风险因素包括母亲年龄≥35岁 (OR=2.115),妊娠高血压 (OR=2.404),妊娠糖尿病 (OR=2.556) 和延迟胆乳分泌 (OR=3.126).

结论:

高风险怀孕与延迟乳腺生成II (DOL II) 的发生率显著增加有关.
母亲年龄35岁以上,妊娠期糖尿病,妊娠期高血压和延迟开始母乳养是DOL II的关键独立风险因素.
加强产前护理,健康教育,强有力的哺乳支持和提高认识对于减轻DOL II流行率至关重要.

关键词:

关心的关心的关心的关心临床临床临床临床临床临床乳腺发育 (lactogenesis) 是一个护理护理护理一个有分量的人.治疗治疗治疗治疗治疗治疗

更多相关视频

X-Ray Visualization of Intraductal Ethanol-Based Ablative Treatment for Prevention of Breast Cancer in Rat Models

X-Ray Visualization of Intraductal Ethanol-Based Ablative Treatment for Prevention of Breast Cancer in Rat Models

Published on: December 9, 2022

Breast Milk Enhances Growth of Enteroids: An Ex Vivo Model of Cell Proliferation

Breast Milk Enhances Growth of Enteroids: An Ex Vivo Model of Cell Proliferation

Published on: February 15, 2018

相关概念视频

Diabetes Mellitus: Type 2 and Gestational

Diabetes Mellitus: Type 2 and Gestational

Type 2 diabetes, characterized by insulin resistance, arises when the insulin receptors on cells lose responsiveness to insulin, diminishing the cell's capacity to take up glucose, resulting in elevated blood glucose levels. To receive a diagnosis of Type 2 diabetes, a series of blood glucose tests are necessary to assess whether the blood glucose falls within normal parameters. If the result is out of the normal range, a patient may be diagnosed as prediabetic or diabetic, depending on the...

Pathophysiology of Diabetes

Pathophysiology of Diabetes

Diabetes mellitus is a chronic metabolic disorder characterized by hyperglycemia. The four categories of diabetes are type 1 diabetes, type 2 diabetes, other specific types of diabetes, and gestational diabetes.
Type 1 diabetes is characterized by autoimmune-mediated destruction of pancreatic β cells, with environmental factors potentially triggering this process in genetically susceptible individuals. Despite many not having a family history, certain genes increase susceptibility,...

Ovarian Cycle

Ovarian Cycle

The menstrual cycle includes a critical component known as the ovarian cycle, which undergoes two main phases each month—the follicular phase and the luteal phase. The follicular phase is variable and averaging around 14 days. Ovulation, triggered by a surge in luteinizing hormone (LH), marks the transition between the two phases. The second phase, the luteal phase, is relatively consistent, lasting approximately 14 days, and is marked by the activity of the corpus luteum. While a cycle...

Glucagon-like Receptor Agonists

Glucagon-like Receptor Agonists

Incretins include glucagon-like peptide-1 (GLP-1) and glucose-dependent insulinotropic polypeptide (GIP), which stimulate insulin secretion post-meals. In type 2 diabetes, GIP's efficacy is reduced, making GLP-1 a viable drug target. GIP originates from preproGIP.
GLP-1, when administered in high doses intravenously, triggers insulin secretion, inhibits glucagon release, slows gastric emptying, reduces food intake, and restores normal insulin secretion. However, its rapid inactivation by...